From Initial Graft Failure to Full Recovery: A Patient’s Journey with Lu Daopei’s Advanced Transplant Protocol
In early 2024, Mr. A’s wife (name anonymized) was diagnosed with high-risk acute B-lymphoblastic leukemia, casting a shadow over what was once a healthy and vibrant life. Initially, she underwent intensive chemotherapy and was admitted for a bone marrow transplant with her father as the donor. However, her hopes were soon dashed when the transplant failed to engraft—a rare but life-threatening complication known as “primary graft failure.”

At this critical juncture, with limited treatment options, Mr. A was presented with a difficult choice: attempt a second transplant. While challenging, the Lu Daopei medical team shared encouraging results from a novel re-transplantation protocol they had developed, boasting an impressive success rate. Filled with renewed hope, the family faced yet another obstacle: finding a matching donor. After 14 relatives were tested with no match, the medical team began a non-relative donor search. Fortune smiled on them, and within a week, a fully matched, unrelated donor was located and agreed to donate.
On September 3, 2024, the second transplant was underway. Nine days post-transplant, her white blood cell count began to rise, and by day 19, she was stable enough to leave isolation, with her blood levels normalizing shortly after. She has since been discharged with consistent results in bone marrow and chimerism tests.
Reflecting on their journey, Mr. A expressed deep gratitude for the support and expertise of the Lu Daopei team, the marrow donor’s generosity, and the medical staff who provided hope in the darkest hours. This experience has strengthened their appreciation for life and underscored the power of persistence, expertise, and compassion in the face of seemingly insurmountable odds.
